Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease. - Wikidata - wikimedia - TriplyDB

Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease.

Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease.

http://www.wikidata.org/entity/Q38219981

about

Anti-dementia medications: current prescriptions in clinical practice and new agents in progress Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging APOE-modulated Aβ-induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective T Cells-Protective or Pathogenic in Alzheimer's Disease?A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies.Pharmacotherapy of Alzheimer's disease: current and future trends.Prospects for strain-specific immunotherapy in Alzheimer's disease and tauopathies.

P2860

Q26795400-690C0F27-EAA9-433C-8C43-47D9C6EC9B88 Q28077869-ED46960B-00E0-4834-B6A0-C49C947007C9 Q28085213-144F8564-4A1E-4948-A6B2-7ABCEE7292AD Q38469322-3DC9E45B-E85D-4824-9968-4EFCDE15301C Q39373266-F471A7E7-4ABE-4AD6-8EDA-97BDBEEF685F Q47783009-A0E6361C-496C-43AB-BFD8-BAE80B2DDC31 Q48532697-EE26F053-FB9A-4914-9142-C69748C9F6E0 Q48678220-312180CD-2F0A-4BBF-88C6-082C8DBFD636 Q50532471-C220CBB4-D84F-4DF5-B808-DD3588B613C8

P2860

Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease.

http://www.wikidata.org/entity/Q38219981

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Anti-amyloid beta to tau - bas ...... therapy for Alzheimer disease.

@en

type

label

Anti-amyloid beta to tau - bas ...... therapy for Alzheimer disease.

@en

prefLabel

Anti-amyloid beta to tau - bas ...... therapy for Alzheimer disease.

@en

P1433

Q38219981-969173FC-8DDD-4839-A7D3-A5C27CBCD66B

P1476

Q38219981-E727A853-03BB-4BD7-8A18-61366E668B86

P2093

Q38219981-FC1CAF5B-03A7-4CBB-866C-71D217C7A393

P2860

Q38219981-00854A3C-EEAD-4AC6-928F-056C309C2028

Q38219981-00B9AAF9-03A1-4E9A-84C9-B019D0A990D4

Q38219981-00C14016-19E5-4AB6-B19B-917164886111

Q38219981-0432DE77-0F35-45F1-957B-53F62BB748E0

Q38219981-053F4C39-BA3B-4ECE-BF5A-99C9C389ECDF

Q38219981-093AE983-EB0D-41E3-AD69-093397F4B814

Q38219981-09FAAFB4-F549-49CD-B824-03A07E582A2D

Q38219981-0A046DC4-03F9-4E0F-BB34-BB2B3FA67846

Q38219981-0AF61A8B-3E07-41C6-9761-B56A9D1CB7B5

Q38219981-0D21123E-E9A2-4D5F-A73F-1BDD9EC52909

P304

Q38219981-F8FAFA3D-13F4-4ACB-9C28-35A3580D1CEA

P31

Q38219981-C1F164E2-8F7C-41EA-A855-C8F0F2CE9DFE

P356

Q38219981-289C5537-D686-4556-9970-26853FB61848

P433

Q38219981-03A7F3B5-EA57-420B-B2C2-BA4E53CF2F8C

P478

Q38219981-D2E655B9-239A-4515-A917-887BD2C06C77

P50

Q38219981-7B217C53-7164-4F54-84F6-2B1D64F6E7CE

P577

Q38219981-A9D81AAA-4156-403E-A104-19AE2798D115

P698

Q38219981-9FC2A1B7-7F17-40AC-8FF7-478F2118DED9

P921

Q38219981-3DEE1F67-931C-4C9E-8A71-03EB19103820

Q38219981-CDA223CE-217F-4DD7-AE21-7296BBA9E225

Q38219981-EF8167D1-D7E5-4536-B9D1-CA2AD99DE682

P932

Q38219981-D094A474-F09B-4771-B38F-9271615FE934

P356

P1433

ImmunoTargets and therapy

P1476

Anti-amyloid beta to tau - bas ...... therapy for Alzheimer disease.

@en

P2093

Roger N Rosenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Transmission and spreading of tauopathy in transgenic mouse brain

Tau and tauopathies

Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

Alzheimer's disease: genes, proteins, and therapy

P304

105-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/ITT.S31428

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

Doris Lambracht-Washington

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24926455

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4051350

http://www.w3.org/2001/XMLSchema#string